🇺🇸 FDA

Intelligence Platform

Patents

Browse 750 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9029502

Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interacti

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9023798

Cystinosin replacement factor

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993519

Method of treatment for neutropenia using stable formulations of recombinant human albumin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987227

Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962817

Vectors encoding a paralytic peptide

Soricimed Biopharma Inc. · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8926987

Replication-competent adenoviral vectors

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8911729

Stem cell factor inhibitor

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8906863

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

The Regents of the University of California · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8901141

Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharma

Takeda Pharmaceutical Company Limited · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8901093

Custom vectors for treating and preventing pancreatic cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8889625

Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial isch

Northwestern University · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8889831

Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypept

Nektar Therapeutics · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865748

Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method fo

Akebia Therapeutics, Inc. · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865461

Rabies virus vector systems and compositions and methods thereof

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8852936

Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy

Laurantis Pharma Oy · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846389

AAV4 vector and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822196

Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of s

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8808684

Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8778870

Modified factor IX polypeptides and uses thereof

Catalyst Biosciences, Inc. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8778633

Transcription factor modulator

Molecular Discover Systems · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8772238

Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765665

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765146

Adenoviral vector-based malaria vaccines

United States of America as represented by the Secretary of the Air Force · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8754081

Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signali

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted